title: The New Zealand Psychoactive Substances Act (PSA): a policy breakthrough or just a symbolic act?
authors.affiliation: Norwegian Institute for Alcohol and Drug Research, Oslo, Norway. alb@sirus.no.
authors.forename: Anne Line
authors.initials: AL
authors.lastname: Bretteville-Jensen
mesh_terms: D015198:Designer Drugs / Q000191:economics*; D004345:Drug Industry; D006801:Humans; D013287:Illicit Drugs / Q000191:economics* / Q000331:legislation & jurisprudence; D007880:Legislation, Drug / Q000191:economics*; D009520:New Zealand; D011619:Psychotropic Drugs / Q000191:economics*
chemical_list: D015198:Designer Drugs; D013287:Illicit Drugs; D011619:Psychotropic Drugs
keywords: Drug legislation and control; NPS manufacturers; New Zealand; economic theory; legal drug production; new psychoactive substance (NPS); psychoactive substance act (PSA)